0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pomalidomide API Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-11Z14525
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pomalidomide API Market Research Report 2023
BUY CHAPTERS

Global Pomalidomide API Market Research Report 2025

Code: QYRE-Auto-11Z14525
Report
February 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pomalidomide API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pomalidomide API Market

Pomalidomide API Market

The global market for Pomalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pomalidomide(CAS:19171-19-8) is a derivative of thalidomide marketed by Celgene.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pomalidomide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide API.
The Pomalidomide API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pomalidomide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pomalidomide API Market Report

Report Metric Details
Report Name Pomalidomide API Market
CAGR 5%
by Type
  • Above 98 %
  • Above 99 %
by Application
  • Capsules
  • Others
Production by Region
  • North America
  • China
  • India
  • Mid East & Africa
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan, Dr. Reddy's Laboratories, Hetero Drugs, Mac-Chem Products (India) Pvt.Ltd, Shilpa Medicare, Veranova, Natco Pharma Limited, Mehta API, Symed Labs Limited, Hangzhou Longshine Bio-Tech, Guangzhou Tosun Pharmaceutical, Sumar Biotech, Deva Holding AS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pomalidomide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pomalidomide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pomalidomide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pomalidomide API Market report?

Ans: The main players in the Pomalidomide API Market are Mylan, Dr. Reddy's Laboratories, Hetero Drugs, Mac-Chem Products (India) Pvt.Ltd, Shilpa Medicare, Veranova, Natco Pharma Limited, Mehta API, Symed Labs Limited, Hangzhou Longshine Bio-Tech, Guangzhou Tosun Pharmaceutical, Sumar Biotech, Deva Holding AS

What are the Application segmentation covered in the Pomalidomide API Market report?

Ans: The Applications covered in the Pomalidomide API Market report are Capsules, Others

What are the Type segmentation covered in the Pomalidomide API Market report?

Ans: The Types covered in the Pomalidomide API Market report are Above 98 %, Above 99 %

1 Pomalidomide API Market Overview
1.1 Product Definition
1.2 Pomalidomide API by Type
1.2.1 Global Pomalidomide API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Pomalidomide API by Application
1.3.1 Global Pomalidomide API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Capsules
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pomalidomide API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pomalidomide API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pomalidomide API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pomalidomide API Production Market Share by Manufacturers (2020-2025)
2.2 Global Pomalidomide API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pomalidomide API, Industry Ranking, 2023 VS 2024
2.4 Global Pomalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pomalidomide API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pomalidomide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pomalidomide API, Product Offered and Application
2.8 Global Key Manufacturers of Pomalidomide API, Date of Enter into This Industry
2.9 Pomalidomide API Market Competitive Situation and Trends
2.9.1 Pomalidomide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pomalidomide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pomalidomide API Production by Region
3.1 Global Pomalidomide API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pomalidomide API Production Value by Region (2020-2031)
3.2.1 Global Pomalidomide API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pomalidomide API by Region (2026-2031)
3.3 Global Pomalidomide API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pomalidomide API Production Volume by Region (2020-2031)
3.4.1 Global Pomalidomide API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pomalidomide API by Region (2026-2031)
3.5 Global Pomalidomide API Market Price Analysis by Region (2020-2025)
3.6 Global Pomalidomide API Production and Value, Year-over-Year Growth
3.6.1 North America Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
3.6.3 India Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Mid East & Africa Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
4 Pomalidomide API Consumption by Region
4.1 Global Pomalidomide API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pomalidomide API Consumption by Region (2020-2031)
4.2.1 Global Pomalidomide API Consumption by Region (2020-2025)
4.2.2 Global Pomalidomide API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pomalidomide API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pomalidomide API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pomalidomide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pomalidomide API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pomalidomide API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pomalidomide API Production by Type (2020-2031)
5.1.1 Global Pomalidomide API Production by Type (2020-2025)
5.1.2 Global Pomalidomide API Production by Type (2026-2031)
5.1.3 Global Pomalidomide API Production Market Share by Type (2020-2031)
5.2 Global Pomalidomide API Production Value by Type (2020-2031)
5.2.1 Global Pomalidomide API Production Value by Type (2020-2025)
5.2.2 Global Pomalidomide API Production Value by Type (2026-2031)
5.2.3 Global Pomalidomide API Production Value Market Share by Type (2020-2031)
5.3 Global Pomalidomide API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pomalidomide API Production by Application (2020-2031)
6.1.1 Global Pomalidomide API Production by Application (2020-2025)
6.1.2 Global Pomalidomide API Production by Application (2026-2031)
6.1.3 Global Pomalidomide API Production Market Share by Application (2020-2031)
6.2 Global Pomalidomide API Production Value by Application (2020-2031)
6.2.1 Global Pomalidomide API Production Value by Application (2020-2025)
6.2.2 Global Pomalidomide API Production Value by Application (2026-2031)
6.2.3 Global Pomalidomide API Production Value Market Share by Application (2020-2031)
6.3 Global Pomalidomide API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Pomalidomide API Company Information
7.1.2 Mylan Pomalidomide API Product Portfolio
7.1.3 Mylan Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 Dr. Reddy's Laboratories
7.2.1 Dr. Reddy's Laboratories Pomalidomide API Company Information
7.2.2 Dr. Reddy's Laboratories Pomalidomide API Product Portfolio
7.2.3 Dr. Reddy's Laboratories Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.3 Hetero Drugs
7.3.1 Hetero Drugs Pomalidomide API Company Information
7.3.2 Hetero Drugs Pomalidomide API Product Portfolio
7.3.3 Hetero Drugs Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hetero Drugs Main Business and Markets Served
7.3.5 Hetero Drugs Recent Developments/Updates
7.4 Mac-Chem Products (India) Pvt.Ltd
7.4.1 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Company Information
7.4.2 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Portfolio
7.4.3 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served
7.4.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
7.5 Shilpa Medicare
7.5.1 Shilpa Medicare Pomalidomide API Company Information
7.5.2 Shilpa Medicare Pomalidomide API Product Portfolio
7.5.3 Shilpa Medicare Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Shilpa Medicare Main Business and Markets Served
7.5.5 Shilpa Medicare Recent Developments/Updates
7.6 Veranova
7.6.1 Veranova Pomalidomide API Company Information
7.6.2 Veranova Pomalidomide API Product Portfolio
7.6.3 Veranova Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Veranova Main Business and Markets Served
7.6.5 Veranova Recent Developments/Updates
7.7 Natco Pharma Limited
7.7.1 Natco Pharma Limited Pomalidomide API Company Information
7.7.2 Natco Pharma Limited Pomalidomide API Product Portfolio
7.7.3 Natco Pharma Limited Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Natco Pharma Limited Main Business and Markets Served
7.7.5 Natco Pharma Limited Recent Developments/Updates
7.8 Mehta API
7.8.1 Mehta API Pomalidomide API Company Information
7.8.2 Mehta API Pomalidomide API Product Portfolio
7.8.3 Mehta API Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Mehta API Main Business and Markets Served
7.8.5 Mehta API Recent Developments/Updates
7.9 Symed Labs Limited
7.9.1 Symed Labs Limited Pomalidomide API Company Information
7.9.2 Symed Labs Limited Pomalidomide API Product Portfolio
7.9.3 Symed Labs Limited Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Symed Labs Limited Main Business and Markets Served
7.9.5 Symed Labs Limited Recent Developments/Updates
7.10 Hangzhou Longshine Bio-Tech
7.10.1 Hangzhou Longshine Bio-Tech Pomalidomide API Company Information
7.10.2 Hangzhou Longshine Bio-Tech Pomalidomide API Product Portfolio
7.10.3 Hangzhou Longshine Bio-Tech Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.10.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.11 Guangzhou Tosun Pharmaceutical
7.11.1 Guangzhou Tosun Pharmaceutical Pomalidomide API Company Information
7.11.2 Guangzhou Tosun Pharmaceutical Pomalidomide API Product Portfolio
7.11.3 Guangzhou Tosun Pharmaceutical Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.11.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
7.12 Sumar Biotech
7.12.1 Sumar Biotech Pomalidomide API Company Information
7.12.2 Sumar Biotech Pomalidomide API Product Portfolio
7.12.3 Sumar Biotech Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Sumar Biotech Main Business and Markets Served
7.12.5 Sumar Biotech Recent Developments/Updates
7.13 Deva Holding AS
7.13.1 Deva Holding AS Pomalidomide API Company Information
7.13.2 Deva Holding AS Pomalidomide API Product Portfolio
7.13.3 Deva Holding AS Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Deva Holding AS Main Business and Markets Served
7.13.5 Deva Holding AS Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pomalidomide API Industry Chain Analysis
8.2 Pomalidomide API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pomalidomide API Production Mode & Process Analysis
8.4 Pomalidomide API Sales and Marketing
8.4.1 Pomalidomide API Sales Channels
8.4.2 Pomalidomide API Distributors
8.5 Pomalidomide API Customer Analysis
9 Pomalidomide API Market Dynamics
9.1 Pomalidomide API Industry Trends
9.2 Pomalidomide API Market Drivers
9.3 Pomalidomide API Market Challenges
9.4 Pomalidomide API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Pomalidomide API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Pomalidomide API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Pomalidomide API Production Capacity (Kg) by Manufacturers in 2024
 Table 4. Global Pomalidomide API Production by Manufacturers (2020-2025) & (Kg)
 Table 5. Global Pomalidomide API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Pomalidomide API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Pomalidomide API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Pomalidomide API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pomalidomide API as of 2024)
 Table 10. Global Market Pomalidomide API Average Price by Manufacturers (US$/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Pomalidomide API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Pomalidomide API, Product Offered and Application
 Table 13. Global Key Manufacturers of Pomalidomide API, Date of Enter into This Industry
 Table 14. Global Pomalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pomalidomide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Pomalidomide API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Pomalidomide API Production Value Market Share by Region (2020-2025)
 Table 19. Global Pomalidomide API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Pomalidomide API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Pomalidomide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 22. Global Pomalidomide API Production (Kg) by Region (2020-2025)
 Table 23. Global Pomalidomide API Production Market Share by Region (2020-2025)
 Table 24. Global Pomalidomide API Production (Kg) Forecast by Region (2026-2031)
 Table 25. Global Pomalidomide API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Pomalidomide API Market Average Price (US$/Kg) by Region (2020-2025)
 Table 27. Global Pomalidomide API Market Average Price (US$/Kg) by Region (2026-2031)
 Table 28. Global Pomalidomide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 29. Global Pomalidomide API Consumption by Region (2020-2025) & (Kg)
 Table 30. Global Pomalidomide API Consumption Market Share by Region (2020-2025)
 Table 31. Global Pomalidomide API Forecasted Consumption by Region (2026-2031) & (Kg)
 Table 32. Global Pomalidomide API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 34. North America Pomalidomide API Consumption by Country (2020-2025) & (Kg)
 Table 35. North America Pomalidomide API Consumption by Country (2026-2031) & (Kg)
 Table 36. Europe Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 37. Europe Pomalidomide API Consumption by Country (2020-2025) & (Kg)
 Table 38. Europe Pomalidomide API Consumption by Country (2026-2031) & (Kg)
 Table 39. Asia Pacific Pomalidomide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 40. Asia Pacific Pomalidomide API Consumption by Region (2020-2025) & (Kg)
 Table 41. Asia Pacific Pomalidomide API Consumption by Region (2026-2031) & (Kg)
 Table 42. Latin America, Middle East & Africa Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 43. Latin America, Middle East & Africa Pomalidomide API Consumption by Country (2020-2025) & (Kg)
 Table 44. Latin America, Middle East & Africa Pomalidomide API Consumption by Country (2026-2031) & (Kg)
 Table 45. Global Pomalidomide API Production (Kg) by Type (2020-2025)
 Table 46. Global Pomalidomide API Production (Kg) by Type (2026-2031)
 Table 47. Global Pomalidomide API Production Market Share by Type (2020-2025)
 Table 48. Global Pomalidomide API Production Market Share by Type (2026-2031)
 Table 49. Global Pomalidomide API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Pomalidomide API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Pomalidomide API Production Value Market Share by Type (2020-2025)
 Table 52. Global Pomalidomide API Production Value Market Share by Type (2026-2031)
 Table 53. Global Pomalidomide API Price (US$/Kg) by Type (2020-2025)
 Table 54. Global Pomalidomide API Price (US$/Kg) by Type (2026-2031)
 Table 55. Global Pomalidomide API Production (Kg) by Application (2020-2025)
 Table 56. Global Pomalidomide API Production (Kg) by Application (2026-2031)
 Table 57. Global Pomalidomide API Production Market Share by Application (2020-2025)
 Table 58. Global Pomalidomide API Production Market Share by Application (2026-2031)
 Table 59. Global Pomalidomide API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Pomalidomide API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Pomalidomide API Production Value Market Share by Application (2020-2025)
 Table 62. Global Pomalidomide API Production Value Market Share by Application (2026-2031)
 Table 63. Global Pomalidomide API Price (US$/Kg) by Application (2020-2025)
 Table 64. Global Pomalidomide API Price (US$/Kg) by Application (2026-2031)
 Table 65. Mylan Pomalidomide API Company Information
 Table 66. Mylan Pomalidomide API Specification and Application
 Table 67. Mylan Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 68. Mylan Main Business and Markets Served
 Table 69. Mylan Recent Developments/Updates
 Table 70. Dr. Reddy's Laboratories Pomalidomide API Company Information
 Table 71. Dr. Reddy's Laboratories Pomalidomide API Specification and Application
 Table 72. Dr. Reddy's Laboratories Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Dr. Reddy's Laboratories Main Business and Markets Served
 Table 74. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 75. Hetero Drugs Pomalidomide API Company Information
 Table 76. Hetero Drugs Pomalidomide API Specification and Application
 Table 77. Hetero Drugs Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Hetero Drugs Main Business and Markets Served
 Table 79. Hetero Drugs Recent Developments/Updates
 Table 80. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Company Information
 Table 81. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Specification and Application
 Table 82. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served
 Table 84. Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
 Table 85. Shilpa Medicare Pomalidomide API Company Information
 Table 86. Shilpa Medicare Pomalidomide API Specification and Application
 Table 87. Shilpa Medicare Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Shilpa Medicare Main Business and Markets Served
 Table 89. Shilpa Medicare Recent Developments/Updates
 Table 90. Veranova Pomalidomide API Company Information
 Table 91. Veranova Pomalidomide API Specification and Application
 Table 92. Veranova Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Veranova Main Business and Markets Served
 Table 94. Veranova Recent Developments/Updates
 Table 95. Natco Pharma Limited Pomalidomide API Company Information
 Table 96. Natco Pharma Limited Pomalidomide API Specification and Application
 Table 97. Natco Pharma Limited Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Natco Pharma Limited Main Business and Markets Served
 Table 99. Natco Pharma Limited Recent Developments/Updates
 Table 100. Mehta API Pomalidomide API Company Information
 Table 101. Mehta API Pomalidomide API Specification and Application
 Table 102. Mehta API Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Mehta API Main Business and Markets Served
 Table 104. Mehta API Recent Developments/Updates
 Table 105. Symed Labs Limited Pomalidomide API Company Information
 Table 106. Symed Labs Limited Pomalidomide API Specification and Application
 Table 107. Symed Labs Limited Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Symed Labs Limited Main Business and Markets Served
 Table 109. Symed Labs Limited Recent Developments/Updates
 Table 110. Hangzhou Longshine Bio-Tech Pomalidomide API Company Information
 Table 111. Hangzhou Longshine Bio-Tech Pomalidomide API Specification and Application
 Table 112. Hangzhou Longshine Bio-Tech Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Hangzhou Longshine Bio-Tech Main Business and Markets Served
 Table 114. Hangzhou Longshine Bio-Tech Recent Developments/Updates
 Table 115. Guangzhou Tosun Pharmaceutical Pomalidomide API Company Information
 Table 116. Guangzhou Tosun Pharmaceutical Pomalidomide API Specification and Application
 Table 117. Guangzhou Tosun Pharmaceutical Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Guangzhou Tosun Pharmaceutical Main Business and Markets Served
 Table 119. Guangzhou Tosun Pharmaceutical Recent Developments/Updates
 Table 120. Sumar Biotech Pomalidomide API Company Information
 Table 121. Sumar Biotech Pomalidomide API Specification and Application
 Table 122. Sumar Biotech Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Sumar Biotech Main Business and Markets Served
 Table 124. Sumar Biotech Recent Developments/Updates
 Table 125. Deva Holding AS Pomalidomide API Company Information
 Table 126. Deva Holding AS Pomalidomide API Specification and Application
 Table 127. Deva Holding AS Pomalidomide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 128. Deva Holding AS Main Business and Markets Served
 Table 129. Deva Holding AS Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Pomalidomide API Distributors List
 Table 133. Pomalidomide API Customers List
 Table 134. Pomalidomide API Market Trends
 Table 135. Pomalidomide API Market Drivers
 Table 136. Pomalidomide API Market Challenges
 Table 137. Pomalidomide API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pomalidomide API
 Figure 2. Global Pomalidomide API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Pomalidomide API Market Share by Type: 2024 VS 2031
 Figure 4. Above 98 % Product Picture
 Figure 5. Above 99 % Product Picture
 Figure 6. Global Pomalidomide API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Pomalidomide API Market Share by Application: 2024 VS 2031
 Figure 8. Capsules
 Figure 9. Others
 Figure 10. Global Pomalidomide API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pomalidomide API Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Pomalidomide API Production Capacity (Kg) & (2020-2031)
 Figure 13. Global Pomalidomide API Production (Kg) & (2020-2031)
 Figure 14. Global Pomalidomide API Average Price (US$/Kg) & (2020-2031)
 Figure 15. Pomalidomide API Report Years Considered
 Figure 16. Pomalidomide API Production Share by Manufacturers in 2024
 Figure 17. Global Pomalidomide API Production Value Share by Manufacturers (2024)
 Figure 18. Pomalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Pomalidomide API Revenue in 2024
 Figure 20. Global Pomalidomide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Pomalidomide API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Pomalidomide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
 Figure 23. Global Pomalidomide API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Pomalidomide API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. China Pomalidomide API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. India Pomalidomide API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Mid East & Africa Pomalidomide API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Pomalidomide API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)
 Figure 29. Global Pomalidomide API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 31. North America Pomalidomide API Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 33. Canada Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 34. Europe Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 35. Europe Pomalidomide API Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 37. France Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 38. U.K. Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 39. Italy Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 40. Russia Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 41. Asia Pacific Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 42. Asia Pacific Pomalidomide API Consumption Market Share by Region (2020-2031)
 Figure 43. China Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 44. Japan Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 45. South Korea Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 46. China Taiwan Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 47. Southeast Asia Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 48. India Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 49. Latin America, Middle East & Africa Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 50. Latin America, Middle East & Africa Pomalidomide API Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 52. Brazil Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 53. Turkey Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 54. GCC Countries Pomalidomide API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 55. Global Production Market Share of Pomalidomide API by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Pomalidomide API by Type (2020-2031)
 Figure 57. Global Pomalidomide API Price (US$/Kg) by Type (2020-2031)
 Figure 58. Global Production Market Share of Pomalidomide API by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Pomalidomide API by Application (2020-2031)
 Figure 60. Global Pomalidomide API Price (US$/Kg) by Application (2020-2031)
 Figure 61. Pomalidomide API Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart